Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2006;37:1184-1188
Published online before print March 30, 2006, doi: 10.1161/01.STR.0000217384.03237.9c
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
37/5/1184    most recent
01.STR.0000217384.03237.9cv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Scigliano, G.
Right arrow Articles by Girotti, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scigliano, G.
Right arrow Articles by Girotti, F.
Related Collections
Right arrow Autonomic, reflex, and neurohumoral control of circulation
Right arrow Risk Factors

(Stroke. 2006;37:1184.)
© 2006 American Heart Association, Inc.


Original Contributions

Reduced Risk Factors for Vascular Disorders in Parkinson Disease Patients

A Case-Control Study

Giulio Scigliano, MD; Massimo Musicco, MD, PhD; Paola Soliveri, MD, PhD; Immacolata Piccolo, MD; Gabriele Ronchetti Floriano Girotti, MD

From the Istituto Nazionale Neurologico "C. Besta" (G.S., P.S., G.R., F.G.), Milano, Italy; the Institute of Biomedical Technologies (M.M.), National Research Council, Segrate (Milano), Italy; and the Niguarda Ca’Granda Hospital (I.P.), Milano, Italy.

Address reprint requests to Floriano Girotti, MD, PhD, Istituto Nazionale Neurologico "C. Besta," Via Celoria 11, 20131 Milano, Italy.

Background and Purpose— Sympathetic hyperactivity is a contributing cause of vascular disorders because it increases blood pressure, blood sugar, and blood lipids. Pervasive compromise of the central and peripheral autonomic nervous systems is common in idiopathic Parkinson disease (IPD) resulting in reduced sympathetic and parasympathetic function. We hypothesized that IPD was associated with reduced prevalence of cardiovascular disease risk factors as a result of reduced sympathetic activity.

Methods— We performed a retrospective case-control study on 178 newly diagnosed consecutive IPD patients, and 533 age- (±3 years) and sex-matched controls with other neurological diseases seen over the same period at the same hospital. For each case and control the following were noted on admission: smoking, diabetes, hypertension, body mass index, serum glucose, plasma cholesterol, triglycerides and total lipid levels, and blood pressure.

Results— Diabetes, history of smoking, high blood pressure, high blood glucose, high blood cholesterol, and triglycerides were significantly less frequent in IPD than controls.

Conclusions— IDP is a natural model of impaired hypothalamic-pituitary-adrenal axis activity and generalized sympathetic denervation. We interpret the association of untreated IPD with reduced vascular diseases risk factors as attributable to reduced autonomic activity, suggesting that autonomic hyperactivity may be involved in the pathogenesis of vascular disorders.


Key Words: cardiovascular disease • cerebrovascular disease • Parkinson disease • risk factors




This article has been cited by other articles:


Home page
Diabetes CareHome page
C. Becker, G. P. Brobert, S. Johansson, S. S. Jick, and C. R. Meier
Diabetes in Patients With Idiopathic Parkinson's Disease
Diabetes Care, September 1, 2008; 31(9): 1808 - 1812.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
G. Hu, R. Antikainen, P. Jousilahti, M. Kivipelto, and J. Tuomilehto
Total cholesterol and the risk of Parkinson disease
Neurology, May 20, 2008; 70(21): 1972 - 1979.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. A. Driver, T. Kurth, J. E. Buring, J. M. Gaziano, and G. Logroscino
Parkinson disease and risk of mortality: A prospective comorbidity-matched cohort study
Neurology, April 15, 2008; 70(16_Part_2): 1423 - 1430.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
K. Ikeda, H. Kashihara, M. Tamura, O. Kano, K. Iwamoto, Y. Iwasaki, G. Hu, P. Jousilahti, and J. Tuomilehto
BODY MASS INDEX AND THE RISK OF PARKINSON DISEASE
Neurology, June 12, 2007; 68(24): 2156 - 2157.
[Full Text] [PDF]


Home page
Diabetes CareHome page
G. Hu, P. Jousilahti, S. Bidel, R. Antikainen, and J. Tuomilehto
Type 2 Diabetes and the Risk of Parkinson's Disease
Diabetes Care, April 1, 2007; 30(4): 842 - 847.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
E. H. Friedman
Reduced Autonomic Activity in Parkinson Disease Patients
Stroke, September 1, 2006; 37(9): 2217 - 2217.
[Full Text] [PDF]